Retinoblastoma natural history, complications, and prognosis: Difference between revisions
No edit summary |
|||
| Line 74: | Line 74: | ||
| 1. single lesion | | 1. single lesion | ||
|- | |- | ||
| 2. multiple lesions | | 2. multiple lesions | ||
|- | |- | ||
| Line 87: | Line 85: | ||
|} | |} | ||
</div> | </div> | ||
===The International Intraocular Retinoblastoma Classification(IIRC)or The ABC classification:=== | |||
{| cellspacing="3" cellpadding="2" | |||
|- | |||
| '''Group A: '''small tumors away from foveola and disc | |||
|- | |||
| • Tumors <3 mm in greatest dimension confined to the retina and | |||
|- | |||
| • Located at least 3 mm from the foveola and 1.5 mm from the optic disc | |||
|- | |||
| '''Group B: '''all remaining tumors confined to the retina | |||
|- | |||
| • All other tumors confined to the retina and not in group A | |||
|- | |||
| • Subretinal fluid (without subretinal seeding) < 3 mm from the base of the tumor | |||
|- | |||
| '''Group C: '''local subretinal fluid or vitreous seeding | |||
|- | |||
| • Subretinal fluid alone >3 mm and < 6 mm from the tumor | |||
|- | |||
| • Vitreous or subretinal seeding < 3 mm from the tumor | |||
|- | |||
| '''Group D: '''diffuse subretinal fluid or seeding | |||
|- | |||
| • Subretinal fluid > 6 mm from the tumor | |||
|- | |||
| • Vitreous or subretinal seeding > 3 mm from the tumor | |||
|- | |||
| '''Group E: '''presence of any one or more of these poor prognosis features | |||
|- | |||
| • More than 2/3 of the globe filled with tumor | |||
|- | |||
| • Tumor in the anterior segment or anterior to the vitreous | |||
|- | |||
| • Tumor in or on the ciliary body | |||
|- | |||
| • Iris neovascularisation | |||
|- | |||
| • Neovascular glaucoma | |||
|- | |||
| • Opaque media from hemorrhage | |||
|- | |||
| • Tumor necrosis with aseptic orbital celullitis | |||
|- | |||
| • Phthisis bulbi | |||
|} | |||
===Survival:=== | ===Survival:=== | ||
| Line 105: | Line 150: | ||
*[[Eye cancer]] | *[[Eye cancer]] | ||
*[[Eye examination]] | *[[Eye examination]] | ||
{{Nervous tissue tumors}} | {{Nervous tissue tumors}} | ||
Revision as of 15:51, 3 May 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Retinoblastoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Retinoblastoma natural history, complications, and prognosis On the Web |
|
American Roentgen Ray Society Images of Retinoblastoma natural history, complications, and prognosis |
|
FDA on Retinoblastoma natural history, complications, and prognosis |
|
CDC on Retinoblastoma natural history, complications, and prognosis |
|
Retinoblastoma natural history, complications, and prognosis in the news |
|
Blogs on Retinoblastoma natural history, complications, and prognosis |
|
Risk calculators and risk factors for Retinoblastoma natural history, complications, and prognosis |
Overview
Retinoblastoma is a cancer of the retina. Development of this tumor is initiated by mutations[1] that inactivate both copies of the RB1 gene, which codes for the retinoblastoma protein.[2]
Prognosis
The prognosis of retinoblastoma depends on the following:
- Whether or not the tumor can be removed by surgery.
- The stage of the cancer: the size of the tumor, whether the cancer has spread
- The child’s general health
Reese-Ellsworth classification(REC) for Retinoblastoma:
The Reese-Ellsworh classification was developed in the 1960s by Dr.Algernon Reese and Dr.Robert Ellsworth, two prominent New York doctors specialising in retinoblastoma. The system was designed to predict outcome from treatment with External beam radiotherapy(EBRT), used internationally as the primary eye salvage treatment until intoduction of chemotherapy in the 1980s.
The REC is rarely used today as chemotherapy has superseded radiotherapy as the favoured treatment for eye salvage.
Group 1: Very favourable for maintenance of sight
A: Solitary tumor, smaller than 4 disc diameters(DD) at or behind the equator
B: Multiple tumors, none larger than 4 DD, all at or behind the equator
Group 2: Favourable for maintenance of sight
A: Solitary tumor, 4 to 10 DD at or behind the equator
B: Multiple tumors, 4 to 10 DD behind the equator
Group 3: possible for maintenance of sight
A: Any lesion anterior to the equator
B: Solitary tumor, larger than 10 DD behind the equator
Group 4: unfavourable for maintenance of sight
A: Multiple tumors, some larger than 10 DD
B: Any lesion extending anteriorly to the ora serrata
Group 5: very unfavourable for maintenance of sight
A: Massive tumors involving more than one half of the retina
B: Vitreous seeding
Essen classification:
International retinoblastoma classification:
| Stage 0: Patients treated conservatively (subject to presurgical ophthalmologic classifications) |
| Stage I: Eye enucleated, completely resected histologically |
| Stage II: Eye enucleated, microscopic residual tumor |
| Stage III: Regional extensiona |
| a) Overt orbital disease |
| b) Preauricular or cervical lymph node extension |
| Stage IV: Metastatic disease |
| a) Hematogenous metastasis: |
| 1. single lesion |
| 2. multiple lesions |
| b) CNS extension: |
| 1. Prechiasmatic lesion |
| 2. CNS mass |
| 3. Leptomeningeal disease |
The International Intraocular Retinoblastoma Classification(IIRC)or The ABC classification:
| Group A: small tumors away from foveola and disc |
| • Tumors <3 mm in greatest dimension confined to the retina and |
| • Located at least 3 mm from the foveola and 1.5 mm from the optic disc |
| Group B: all remaining tumors confined to the retina |
| • All other tumors confined to the retina and not in group A |
| • Subretinal fluid (without subretinal seeding) < 3 mm from the base of the tumor |
| Group C: local subretinal fluid or vitreous seeding |
| • Subretinal fluid alone >3 mm and < 6 mm from the tumor |
| • Vitreous or subretinal seeding < 3 mm from the tumor |
| Group D: diffuse subretinal fluid or seeding |
| • Subretinal fluid > 6 mm from the tumor |
| • Vitreous or subretinal seeding > 3 mm from the tumor |
| Group E: presence of any one or more of these poor prognosis features |
| • More than 2/3 of the globe filled with tumor |
| • Tumor in the anterior segment or anterior to the vitreous |
| • Tumor in or on the ciliary body |
| • Iris neovascularisation |
| • Neovascular glaucoma |
| • Opaque media from hemorrhage |
| • Tumor necrosis with aseptic orbital celullitis |
| • Phthisis bulbi |
Survival:
The survival for children diagnosed with retinoblastoma in the period 1975-94 was quite favourable, with more than 93% alive at five years after diagnosis and males and females had similar 5 year survival rates for the period 1975-94 and black children had slightly lower survival rates than white children.(89% versus 94%)[3] Trilateral retinoblastoma has a poor prognosis, especially when tumor spreads to the sub-arachnoid space.[4] After a pineal or sellar mass is detected, the mean length of survival is 9.7 months in patients who undergo treatment and 1.3 months in those who do not.[5]
Possible complications
- Local spread of tumor.
- Development of other tumors.
- Cataract from radiotherapy.
- Failure of tooth eruption after radiotherapy.
- Bony deformities
References
- ↑ Knudson A (1971). "Mutation and cancer: statistical study of retinoblastoma". Proc Natl Acad Sci U S A. 68 (4): 820–3. PMID 5279gadgqetqer523 Check
|pmid=value (help). - ↑ Friend S, Bernards R, Rogelj S, Weinberg R, Rapaport J, Albert D, Dryja T. "A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma". Nature. 323 (6089): 643–6. PMID 2877398.
- ↑ http://seer.cancer.gov/publications/childhood/retinoblastoma.pdf
- ↑ Provenzale JM, Gururangan S, Klintworth G (2004). "Trilateral retinoblastoma: clinical and radiologic progression". AJR. American Journal of Roentgenology. 183 (2): 505–11. PMID 15269048. Retrieved 2012-05-02. Unknown parameter
|month=ignored (help) - ↑ Holladay DA, Holladay A, Montebello JF, Redmond KP (1991). "Clinical presentation, treatment, and outcome of trilateral retinoblastoma". Cancer. 67 (3): 710–5. PMID 1985763. Unknown parameter
|month=ignored (help);|access-date=requires|url=(help)